News Hub | News Direct

Elsevier partners with the Society for Mucosal Immunology to publish Mucosal Immunology

Elsevier

The Society for Mucosal Immunology (SMI), the preeminent international community of researchers working together to advance the field of mucosal immunology and improve health worldwide, and Elsevier, a global leader in research publishing and information analytics, are delighted to announce a new partnership to publish SMI’s official journal, Mucosal Immunology. The journal will transition to gold open access, making articles immediately and permanently available for everyone to read, download, copy and distribute. It will be hosted on Elsevier’s leading online platform, ScienceDirect, beginning January 2023. SMI’s decision to partner with Elsevier furthers its ongoing mission to directly support research and education and foster communication and collaboration in the field of mucosal immunology. Transitioning its journal from its current subscription model to gold open access clearly reflects its commitment to make its content more easily accessible and drive innovation in the field. SMI President Michael McGuckin, PhD, said: “We welcome Elsevier as our new publisher and look forward to taking advantage of its publishing expertise and commitment to open science as we continue our journey to increase the visibility and influence of Mucosal Immunology together. It is clear from our early interactions with Elsevier staff and leadership that this will be a partnership in the truest sense of the word and enable us to build upon the journal’s high standards and further enhance its global prominence.” Since 1990, mucosal immunology has expanded from what many considered a niche discipline to one of the hottest areas in immunobiology today, underpinned by interactions with the microbiome and nervous system that have profound implications for health and disease. The journal fosters cross-fertilization between scientists, clinical researchers and industry professionals across a broad spectrum of specialties working on pathways of immunity and inflammation at barrier surfaces. They rely on Mucosal Immunology for the very latest robust, cutting-edge original research and reviews in basic, translational and clinical science. The journal has earned a strong reputation for publishing papers based on the quality of the science, its rapid and rigorous peer review, and its contributions to advancing the field. This is demonstrated by its impressive 2021 Journal Impact Factor of 8.701* and a steadily increasing online and social media community. “The editorial board and I are tremendously excited for the opportunity to partner with Elsevier to publish Mucosal Immunology,” said Professor Marsland. “I have every confidence that support from the Elsevier team will foster even greater success in our ongoing efforts to publish novel, transformative, and clinically relevant science. On behalf of Mucosal Immunology ’s editors, editorial staff, reviewers, and authors, I want to welcome our new partner. Ben Marsland, PhD Elsevier is firmly committed to the continuity of the journal’s rigorous editorial process and accessibility of content, and further solidifying Mucosal Immunology ’s reputation. “We are delighted that SMI has selected Elsevier as its publishing partner. By combining their expertise with Elsevier’s industry-leading resources for authors, editors, peer reviewers and readers, we will ensure the best possible support for SMI’s mission and community. By working together, we can achieve a more inclusive, collaborative and transparent world of research,” stated Louise Curtis, Senior Vice President, Life Sciences & Social Sciences, at Elsevier. “ Mucosal Immunology is a great asset to the Elsevier immunology journal portfolio, and we look forward to helping the society and their journal navigate a successful transition to full open access status,” added Jenny Henzen, Elsevier’s Publisher for Immunology. *Journal Citation Reports, Clarivate, 2022 About Mucosal Immunology Mucosal Immunology is the official publication of the Society for Mucosal Immunology (SMI). It aims to provide a forum for both basic and clinical scientists to discuss all aspects of immunity and inflammation involving barrier tissues. The journal reflects the interests of scientists studying gastrointestinal, pulmonary, nasopharyngeal, oral, ocular, genitourinary and skin immunology through the publication of original research articles, scholarly reviews, and timely commentaries. Publication of basic, translational, and clinical studies are given equal consideration. In addition, Mucosal Immunology aims to provide a primary method of communication for the SMI governing board and its members through the publication of society news, announcements of planned meetings and conferences, discussions of policy concerns, and advertisements for job and training opportunities. Beginning January 2023, all articles will be published as gold open access through CC BY licenses. About the Society for Mucosal Immunology (SMI) The Society for Mucosal Immunology was formed in 1987 to advance research and education related to the field of mucosal immunology. With a mission to support research and education, and foster communication and collaboration in the field of mucosal immunology, the society represents a diverse group of over 700 scientists and clinicians from all over the world. https://www.socmucimm.org About the Editor-in-Chief Ben Marsland completed his PhD in Immunology at Otago University and the Malaghan Institute of Medical Research, Wellington, New Zealand. He then spent 14 years in Switzerland, first at the ETH Zürich and then as a Cloetta Medical Research Fellow at the University Hospital of Lausanne (CHUV). During that period, he received the ETH Latsis Prize, the Leenaards Prize and the ERS COPD Research Award. Since 2018, Ben is a veski innovation fellow, NHMRC Senior Research Fellow and Professor in the Department of Immunology and Pathology within the Central Clinical School at Monash University. He also maintains a visiting professorship at the University of Lausanne and CHUV. The focus of Ben’s lab revolves around the microbiome in the gut, lung and skin and how it influences asthma, respiratory viral infections and lung fibrosis. About Elsevier and society partnerships Elsevier has long-standing partnerships with over 600 learned societies worldwide, helping them to realize their missions and inspire and support their communities. We pride ourselves on consistently delivering outstanding publishing outcomes through strategic insight, reliable finances, global dissemination, embracing open science and open access, and championing the needs of the communities we jointly serve. www.elsevier.com/societies About Elsevier As a global leader in information and analytics, Elsevier helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. We do this by facilitating insights and critical decision-making for customers across the global research and health ecosystems. In everything we publish, we uphold the highest standards of quality and integrity. We bring that same rigor to our information analytics solutions for researchers, health professionals, institutions and funders. Elsevier employs 8,700 people worldwide. We have supported the work of our research and health partners for more than 140 years. Growing from our roots in publishing, we offer knowledge and valuable analytics that help our users make breakthroughs and drive societal progress. Digital solutions such as ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath support strategic research management, R&D performance, clinical decision support, and health education. Researchers and healthcare professionals rely on our over 2,700 digitized journals, including The Lancet and Cell; our over 43,000 eBook titles; and our iconic reference works, such as Gray's Anatomy. With the Elsevier Foundation and our external Inclusion & Diversity Advisory Board, we work in partnership with diverse stakeholders to advance inclusion and diversity in science, research and healthcare in developing countries and around the world. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com Contact Details Elsevier Jenny Henzen, Publisher, Immunology j.henzen@elsevier.com Company Website https://www.elsevier.com/

July 18, 2022 04:00 AM Eastern Daylight Time

Image

Asia’s only diagnostic-first sexual health wellness startup Kindly secures funding round

Kindly

Health tech startup Kindly has set out to support men and women across asia dealing with sexual lifestyle disorders and fertility issues with a diagnostic-first approach. As they seek to grow and expand, Kindly has today announced a $3.25M seed round from investors around the world including Y Combinator, DG Daiwa, Olive Tree, Soma, Goodwater, and Gaingels. Founded in 2020 (previously known as Janani.life), Kindly is a holistic sexual performance and a lifestyle brand focussed on the sexual & reproductive health space. They are addressing the gap in the market of lifestyle disorders, sexual performance, and hormonal wellness – a $8b market opportunity - with their support and product range. The YCombinator (W22 cohort) backed start-up, Kindly is Asia’s only diagnostics-first lifestyle brand offering a full-stack sexual wellness solution, including at-home diagnostics, convenient expert consultations, and doctor-backed supplements. Kindly is the only brand in India to offer at-home-semen tests that are not only focused on fertility issues but also on lifestyle disorders, which are extremely common among men and women today. Kindly is addressing a marketplace of 130 million users in India alone who will benefit from Kindly’s full stack approach by early diagnosis of lifestyle disorder, expert doctor consultations and research backed supplements to overcome and manage lifestyle disorders such as sexual dysfunctions, low vitality, PCOS and menstrual pain. Nilay Mehrotra, Founder & CEO of Kindly, commented: “We’ve attracted investors from around the world and this bodes well for our expansion into markets beyond India. The whole team is passionate about empowering people to explore their sexual wellness safely and confidently and this shows in our community engagement and growth numbers. We’re breaking new ground with an all-inclusive approach to lifestyle and sexual disorders, something which hasn’t been done before. The funding round wil elevate us from from a disruptor brand to a market leader in the lifestyle and sexual wellness market. With fresh product lines, a tech-enabled platform for easy access to our services, and our intention for global expansion, we are poised to enter the next phase of our growth.” Kindly’s offerings are categorised into KindlyHis and KindlyHers to address the needs of both genders. KindlyHis is predominantly leading the conversation about sexual performance and sperm health whereas KindlyHers focuses on women’s holistic wellness offering products and services for sexual, menstrual, and hormonal wellness. Both men and women face sexual wellness concerns but due to lack of awareness and social stigma associated with these problems they refrain from seeking help. Erectile dysfunction, premature ejaculation and loss of libido are one of the major concerns for men. According to research, Prevalence of female sexual dysfunction increased with age, from 22% in women aged <20 years to 75.7% in women aged 40-50 years. Most women suffer from painful sex, vaginusmus, vaginal dryness and loss of libido but in most cases it is ignored due lack of knowledge. Kindly will use the capital to accelerate its growth and expansion across India and international markets. “As a growth-stage investor focused on bio health led businesses, we are excited to partner with Kindly. The wellness market has changed dramatically over the last year, and we believe the demand for at home diagnostics will only continue to grow. Kindly's diagnostics first based model is well positioned for success, and we believe it has the potential to grow” added Takeshi Kanamori, Managing Director, DG Daiwa ventures. About Kindly Kindly is a holistic sexual performance and a lifestyle brand for all, offering discreet, non-judgmental, convenient, end-to-end full-stack solutions. Launched in May 2022 by Nilay Malhotra and Raj Garg, the Bengaluru-based start-up provides an end-to-end, research-backed solution for sperm health & sexual performance for men, PCOS, irregular periods & period pain for women, and low libido for women. Kindly has two verticals: Kindly His and Kindly Hers. Kindly His is predominantly leading the conversation about sexual performance and sperm health whereas Kindly Hers focuses on women’s holistic wellness offering products and services for sexual, menstrual, and hormonal wellness. For more information, please visit: https://www.kindlyhealth.com/ Contact Details Kindly Bilal Mahmood +44 7714 007257 b.mahmood@stockwoodstrategy.com Company Website https://www.kindlyhealth.com/

July 14, 2022 09:00 AM Eastern Daylight Time

Image

Unocoin Collaborates With CleverTap to Offer Its Users Omnichannel Customer Experiences

CleverTap

CleverTap, the modern, integrated retention cloud, today announced it has partnered with Unocoin, India’s first crypto exchange, to optimize, accelerate their user engagement, and provide a seamless omnichannel customer experience. Through this collaboration, and by integrating CleverTap’s solution into its app, Unocoin is now equipped to better understand user behavior and has the ability to create segments based on user activity, demographics, and other parameters. Unocoin will also be able to create hyper-personalized campaigns to engage with its audience across multiple channels at the right time with precise communication. “As a platform that helps individuals with investments into cryptocurrencies, we need to be cognizant of the exact needs of our users. Understanding a customer’s behavior on our app becomes vital as this helps us provide a tailored experience. Since awareness and understanding of cryptocurrencies at large is at a nascent stage, delivering precise communication becomes all the more important,” said Suhas SK, Senior Vice President - Marketing, Unocoin Technologies Private Limited. CleverTap enables Unocoin to keep track of app activity, in-app purchases, and returning users. Unocoin will also be able to personalize customer experience using real-time behavioral data with precise predictive recommendations, leading to engagement opportunities based on each user’s exact needs. “We are delighted to partner with Unocoin in their journey to make investing in cryptocurrency easy for all. With CleverTap Retention Cloud, Unocoin will be able to hyper-personalize the experience for every investor. Today, hyper-personalization is crucial at every point in a customer’s journey and is a key enabler to growth. We are confident that with our help, Unocoin will be able to grow and offer its customers exactly what they need,” said Vikrant Chowdhary, Chief Growth Officer, CleverTap. About CleverTap CleverTap is the modern, integrated retention cloud that empowers digital consumer brands to increase customer retention and lifetime value. CleverTap drives contextual individualization with the help of a unified and deep data layer, AI/ML-powered insights, and automation enabling brands to offer hyper-personalized and delightful experiences to their customers. 1,200+ customers in 60+ countries and 10,000+ apps, including Gojek, ShopX, Canon, Mercedes Benz, Electronic Arts, TED, Jio, Premier League, TD Bank, Carousell, Papa John’s, and Tesco, trust CleverTap to achieve their retention and engagement goals, growing their long-term revenue. Backed by leading venture capital firms, including Sequoia, Tiger Global Management, and Accel, the company is headquartered in Mountain View, California, with offices in Mumbai, Singapore, Sofia, São Paulo, Bogota, Amsterdam, Jakarta, and Dubai. For more information, visit clevertap.com or follow on LinkedIn and Twitter. About Unocoin Started in 2013, Unocoin is a Bangalore-based technology startup and is India’s first entrant into the bitcoin industry. The company operates India’s largest (in Indian customer base) BTC-INR trading platform which enables Indians to buy, sell, store, use, and accept bitcoin. At its peak, Unocoin processed transactions worth more than INR 2B per month for its 1,300,000+ customers. The startup has been featured among the Top 20 companies in The Fintech20: India List, and have won prestigious titles like ‘The Golden SABRE award’ in financial communications for the project, ‘Bit-by-Bit: Building Bitcoin in India’ and ‘TECH30’ award from YourStory.For more information, visit https://www.unocoin.com/in Forward-Looking Statements Some of the statements in this press release may represent CleverTap's belief in connection with future events and may be forward-looking statements, or statements of future expectations based on currently available information. CleverTap cautions that such statements are naturally subject to risks and uncertainties that could amount in the actual result being absolutely different from the results anticipated by the statements mentioned in the press release. Factors such as the development of general economic conditions affecting our business, future market conditions, our ability to maintain cost advantages, uncertainty with respect to earnings, corporate actions, client concentration, reduced demand, liability or damages in our service contracts, unusual catastrophic loss events, war, political instability, changes in government policies or laws, legal restrictions impacting our business, impact of pandemic, epidemic, any natural calamity and other factors that are naturally beyond our control, changes in the capital markets and other circumstances may cause the actual events or results to be materially different, from those anticipated by such statements. CleverTap does not make any representation or warranty, express or implied, as to the accuracy, completeness or updated or revised status of such statements. Therefore, in no case whatsoever will CleverTap and its affiliate companies be liable to anyone for any decision made or action taken in conjunction with the information and/or statements in this press release or any related damages. Contact Details Sony Shetty sony@clevertap.com Company Website https://clevertap.com/

July 14, 2022 04:12 AM Eastern Daylight Time

#scheinchat: How to Optimize Billing in the Dental Practice

Henry Schein

Contact Details Henry Schein, Inc. Claire Barbier +1 631-454-3657 claire.barbier@henryschein.com Company Website https://www.henryschein.com

July 13, 2022 08:00 AM Eastern Daylight Time

Video

Elsevier Launches Global Collaboration to Understand the Impact of the Pandemic on Confidence in Scientific Research

Elsevier

Elsevier, a global leader in research publishing and information analytics, has today announced the launch of a global collaboration that will include new, independent research led by Economist Impact. The initiative aims to assess the drivers of confidence in research, examine how researchers have experienced the increased public attention on science during the pandemic, and the implications this has had on the academic research community. It is also looking at changes in the ways in which researchers communicate their findings. A main focus of the initiative will be a landmark global survey conducted by Economist Impact, experts in helping to identify critical and actionable insights, of 3,000 researchers across Europe, North America, Latin America, Middle East, Africa, and Asia. The insights will be published in a free report in Autumn 2022, and be used to create a set of actionable commitments and recommendations that will support researchers in their efforts to advance knowledge that benefits society. The initiative sees Elsevier partner with Sense about Science, which has pioneered wider engagement on the reliability of research internationally, to bring together world-renowned experts to advise and inform the collaboration via a Global Advisory Board tasked with shaping the primary research, and a Global Expert Panel that will drive the co-creation of actionable insights and recommendations to benefit the research community. Elsevier is also working in partnership with leading science and research organisations in six regions: Chinese Association for Science of Science and Science & Technology Policy (China) Körber Stiftung (Germany) Japanese Association for the Advancement of Science (Japan) Koninklijke Hollandsche Maatschappij der Wetenschappen - Royal Holland Society of Sciences and Humanities (Netherlands) Sense about Science (UK & global) Research!America (US) These organisations will bring unique perspectives from their respective countries, and co-host roundtables with Elsevier to explore the findings and discuss potential recommendations the collaboration will put forward. Anne Kitson, Senior Vice President and Managing Director of Cell Press and The Lancet, Elsevier said: “Ensuring quality research can accelerate progress for society is at the heart of what Elsevier does. Science is making extraordinary advances at an accelerated pace, but amid this change lie new challenges for researchers. We’re privileged to partner with and bring together some of the world’s leading experts to consider these challenges, and work towards recommendations that we hope will help researchers to navigate this fast-evolving scientific landscape.” Tracey Brown, Director, Sense about Science, said: “This work builds on our long-standing collaboration with Elsevier to support initiatives that improve understanding of research quality and accessible findings. If researchers have questions about the reliability of research on which to build, then these are also questions for the public and how we more broadly place confidence in findings. We are looking to this initiative to provide more of an evidence base on which initiatives can be developed and benchmarked.” Jonathan Birdwell, Regional Head of Policy Research & Insights for EMEA, Economist Impact said: “2020 was a landmark year for scientific research. The development of Covid-19 vaccines marked an extraordinary achievement for science and global scientific cooperation. The pandemic turned previously unknown researchers into household names, with politicians, business leaders and the general public more invested than ever before in the outcomes of the scientific process. But the pandemic also appears to have accelerated a number of longer-term trends affecting the research community, including the speed and volume of research published and the role of social media. What impact has the pandemic had on how researchers produce and communicate their research? How do researchers’ experiences differ by geography, gender identity and career stage? What types of tools and resources do researchers need to produce and communicate research effectively? Our research hopes to answer these questions and identify solutions that could help researchers navigate this changing landscape with confidence.” The collaboration comes as Elsevier’s Research Futures report reveals that the most cited ‘red flags’ for researchers to engage with and trust research was the source of data being unclear (60%), the journal being of low quality (57%) and the research not being peer reviewed (55%). The report, which surveyed over 1,000 researchers globally, also found that the most stated challenges to effective communication of research were pressure to publish to advance your career (63%), the sheer volume of articles being published (51%), and the growing emphasis on demonstrating novelty in research (47%). Researchers also reported an increase in their use of sharing sites, academic community platforms, and publisher websites. --- Notes to editors Global Advisory Board members include: Dr. Agnes Binagwaho, Vice-Chancellor, University of Global Health Equity, Rwanda Dr. Cary Funk, Director of science and society research, the Pew Research Center Dr. John Grove, Director of Quality Assurance for Norms & Standards, World Health Organisation Dr. Heide Hatheckmann, Senior Advisor for Transdisciplinarity and Global Knowledge Networks, Centre for the Advancement of Scholarship of the University of Pretoria and Interim Director for Future Africa. Dr. Richard Horton, Editor-in-chief, The Lancet Dr. Reiko Kuroda, Professor at Chubu University, Japan and Professor Emeritus at The University of Tokyo Dr. Nick Perkins, Board Member, International Science Council Dr. John Pham, Editor-in-chief, Cell Dr. Wim van Saarloos, Chair of the Energy Programme, European Academies Science Council (EASAC); Professor of theoretical physics, the Instituut-Lorentz, University of Leiden Dr. Michael Saliba, Professor and Head of the Institute of Photovoltaics, University of Stuttgart and Co-chair, Global Young Academy Dr. Karla Soares-Weiser, Editor-in-chief, Cochrane Dr. Jack Stilgoe, Professor of Science and Technology Policy, Dept of Science & Technology Studies, Faculty of Maths & Physical Sciences, University College London Dr. Sheila Jasanoff, Pforzheimer Professor of Science and Technology Studies, John F. Kennedy School of Government, Harvard University About Sense about Science Sense about Science is an independent non-profit that promotes the public interest in sound science and evidence. It produced the first public guide to peer review, ‘I Don’t Know What to Believe’ over a decade ago, and has since produced the first international guide to data science, co-created with user groups around the world. With its AllTrials campaign, with patients, doctors and researchers, it has achieved major changes in international regulation and compliance on the publication of clinical trial results. Sense about Science will chair the Global Expert Panel, to develop plans for improving scientific practices and helping researchers and the public to navigate research outputs. It will represent UK-based stakeholders as the local Regional Convening Partner, to draw people into a discussion of what actions and interventions researchers, scholarly publishers, universities, funders and others can make to improve confidence in research in the UK. About Economist Impact Economist Impact combines the rigour of a think-tank with the creativity of a media brand to engage a globally influential audience. We believe that evidence-based insights can open debate, broaden perspectives and catalyse progress across three core areas of expertise and leadership including sustainability, new globalisation and health. The services offered by Economist Impact previously existed within The Economist Group as separate entities, including EIU Thought Leadership, EIU Public Policy, Economist Events and SignalNoise. Our track record spans 75 years across 205 countries. Along with creative storytelling, events expertise, design-thinking solutions and market-leading media products, we produce framework design, benchmarking, economic and social impact analysis, forecasting and scenario modelling, making Economist Impact's offering unique in the marketplace. Visit www.economistimpact.com for more information. About Elsevier As a global leader in information and analytics, Elsevier helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. We do this by facilitating insights and critical decision-making for customers across the global research and health ecosystems. In everything we publish, we uphold the highest standards of quality and integrity. We bring that same rigor to our information analytics solutions for researchers, health professionals, institutions and funders. Elsevier employs 8,700 people worldwide. We have supported the work of our research and health partners for more than 140 years. Growing from our roots in publishing, we offer knowledge and valuable analytics that help our users make breakthroughs and drive societal progress. Digital solutions such as ScienceDirect, Scopus, SciVal, ClinicalKey and Sherpath support strategic research management, R&D performance, clinical decision support, and health education. Researchers and healthcare professionals rely on our 2,700+ digitized journals, including The Lancet and Cell; our 43,000+ eBook titles; and our iconic reference works, such as Gray's Anatomy. With the Elsevier Foundation and our external Inclusion & Diversity Advisory Board, we work in partnership with diverse stakeholders to advance inclusion and diversity in science, research and healthcare in developing countries and around the world. Elsevier is part of RELX, a global provider of information-based analytics and decision tools for professional and business customers. www.elsevier.com Contact Details Andrew Davis andrew.davis@elsevier.com Andrea White a.white@elsevier.com Company Website https://www.elsevier.com/

July 13, 2022 04:00 AM Eastern Daylight Time

Nearly Half a Million Young People Are Quitting E-cigarettes Through Text: First-of-its-kind program from truth® is helping young people quit vaping nicotine

YourUpdateTV

A video accompanying this announcement is available at: https://youtu.be/qb2xLRu2VOQ E-cigarette use among young people remains at epidemic levels with nearly one in five high school students using e-cigarettes and approximately 40% of users doing so on a regular basis, according to recent data. What can be done to turn around this troubling trend? Text message programs are available to help young people on their quitting journey. This is Quitting from truth is a free and anonymous text messaging program designed to help young people quit vaping nicotine. The first-of-its-kind quit program incorporates messages from real young people like them who have attempted to, or successfully quit, e-cigarettes. Results from a clinical trial demonstrate the effectiveness of the program and found that This is Quitting from truth increased quit rates among young adults aged 18-24 by nearly 40% compared to a control group. How it works To enroll in This is Quitting, teens and young adults can text DITCHVAPE to 88709. The first messages they receive will ask for their age and product usage so that they are able to receive relevant messages. Users receive one age-appropriate message per day tailored to their enrollment date or quit date, which can be set and reset via text message. Those who are not ready to quit receive at least four weeks of messages focused on building skills and confidence. Users with a quit date receive one week of messages prior to that date and at least eight weeks of messages after their quit date. Throughout the program, users can text COPE, STRESS, SLIP or MORE to receive instant support. Upon completion of the program, users receive periodic text messages from truth and may continue to use supportive keywords for as long as they like. For more information, visit TRUTHINITIATIVE.ORG Teens and young adults can join for free by texting DITCHVAPE to 88709. Contact Details YourUpdateTV +1 212-736-2727 yourupdatetv@gmail.com

July 11, 2022 04:00 PM Eastern Daylight Time

Video

Lauren Lawson-Zilai Joins Shatterproof® as Senior Director, Media and Public Relations

Shatterproof

Lauren Lawson-Zilai has been appointed to senior director, media and public relations of Shatterproof, a national nonprofit organization dedicated to reversing the addiction crisis in the U.S. She joins the organization in a new position to develop and implement a national communications and media strategy to advance public awareness of Shatterproof. In this role, Lawson-Zilai will position the organization and key leadership as thought leaders, garner awareness nationally and in key markets, and manage key partnerships with the media. Lawson-Zilai joins Shatterproof after spending the past 15 years with Goodwill Industries International as head of public relations and as a spokesperson. In that role, she led strategic communications for North America’s leading nonprofit provider of education, training and career services for millions of people with disadvantages and disabilities. During her tenure, she launched Goodwill’s first influencer marketing program, which included notable engagements like the BeyGOOD campaign with Beyoncé as well as celebrity and ambassador relationships with PBS’ Matt Paxton, TODAY Show’s Evette Rios and Sugarland’s Kristian Bush. She also led the public relations for two long-running public service campaigns between Goodwill and the Ad Council, known as the “Bring Good Home” and “Donate Stuff, Create Jobs” campaigns. Within the last year, she was instrumental in launching Rising Together™, a unique initiative to equip 1 million people with sustainable careers by 2025 and securing partnerships with global philanthropic partners and Fortune 50 companies such as, Bank of America and Google. “Lauren Lawson-Zilai is joining Shatterproof at a critical time as we see addiction and overdoses grow in our country. In 2021, there were nearly 108,000 drug overdose deaths in the U.S.—the most ever recorded, and a 15% increase over 2020. This is in addition to the more than 99,000 Americans who died in 2020 from alcohol-related causes. Shatterproof is dedicated to ending the devastation caused by this disease, and its focus is on revolutionizing addiction treatment, ending stigma and shame, and educating and empowering communities,” shared Kirsten Suto Seckler, chief marketing and communications officer at Shatterproof. “Lauren will help make sure that more families across the country are aware of life-saving resources being developed by Shatterproof and she will help break down the stigma of addiction in our country.” Lawson-Zilai has spent most of her career using marketing and communications to drive social change and impact and elevate the brand awareness of mission-driven nonprofit organizations in both paid and pro bono capacities. She was recently recognized as Ragan Communications’ Top Women in Communications. She is also a recipient of the Top Women in PR Award from PRNews and a Washington Women in Public Relations PR Woman of the Year (WWPR) honoree. She has received industry awards from the Association of Women in Communications, the Mobile Marketing Association, the Public Relations Society of America (PRSA) and SMARTIES for her work. In addition, she served on the PRSA Voices4Everyone taskforce, which focused on inclusive, civil discourse through diversity, equity and inclusion (DEI), civic engagement, and combating disinformation and civility, and steered the strategic direction of WWPR as part of its advisory council. Lawson-Zilai is currently a member of the Girl Scouts Nation’s Capital Women’s Advisory Board, the Editorial Advisory Board for Ragan Communications and PR Daily, the National Press Club Communicators Committee, the Board of Advisors for the National Digital Roundtable and the President’s Leadership Council for Lycoming College, her alma mater. About Shatterproof: Shatterproof is a national nonprofit organization dedicated to reversing the addiction crisis in the U.S. Shatterproof harnesses the models of business, the rigor of science and the power of a national movement to create change and save lives through three pillars of work: revolutionizing the addiction treatment system, breaking down addiction-related stigmas and supporting and empowering our communities. Find Shatterproof on Facebook, Twitter and YouTube: @ShatterproofHQ or follow them on Instagram at @weareshatterproof. To learn more, visit www.Shatterproof.org. Contact Details Shatterproof Press +1 240-910-5483 press@shatterproof.org Company Website https://www.shatterproof.org/

July 11, 2022 03:51 PM Eastern Daylight Time

‘Ready for Ron’ Releases Research Illustrating Growing Positive Sentiment for DeSantis

Ready for Ron

Today, Ready for Ron, a draft committee encouraging Florida Governor Ron DeSantis to run for President, released research it commissioned from Impact Social showing growing support for Governor DeSantis. The report shows positive sentiment for Governor Ron DeSantis grew 8 points from an earlier analysis released last week. Impact Social researchers analyzed the publicly available social media discussion in relation to Ron DeSantis and Donald Trump among swing voters from June 15 to June 29, 2022. Additional reports are expected every two weeks. Previous reports can be found here. “We carried out detailed language analysis of US social media discussions back to May 2016 to capture social media users into a database of 40,000 swing voters,” explained Phil Snape, Director at Impact Social. “With 40,000 participants, we are operating what is likely the world’s largest focus group – as big as a Football stadium.” The summary of Impact Social’s second report states: The last fortnight has been a productive period for Ron DeSantis which has seen his net sentiment jump 8 pts (-14 to -6) among floating voters. Within the positive conversation (+2pts 19 to 21), those hoping to persuade DeSantis to run for president will be delighted to see the leading topic within this discussion is how they prefer DeSantis to Trump (33%). It is worth emphasizing these opinions are posted without coercion or provocation. These floating voters are merely stating online how they favor the younger man as their next president. A small percentage (4%) are even outing themselves as Democrats before volunteering their support should DeSantis stand. Intriguingly, there is a feeling among his supporters that a sense of momentum is developing around his potential presidential candidacy. They speak excitedly about a poll in NH, an ‘endorsement’ by Elon Musk or simply muse that DeSantis’ ‘is where the smart money is’, that ‘Dems want Trump because they can’t beat DeSantis’ or that Fox will happily anoint him as leader of the GOP when the time arises. A downward trend in the number of negative posts against DeSantis (-5pts 33 to 27) will be welcomed by his camp. Yet their boss continues to take hits from across the political spectrum as some GOP voters see him as too right wing and pine for a leader dedicated to smaller government. That said, the majority of criticism stems from the left who see DeSantis as an overbearing authoritarian. They use DeSantis’ recent decision not to order Covid -19 vaccination for FL kids as a prime example of what he is capable of. This, together with perceived attacks on LGBT rights and support for gun laws increases anxiety among the left many of whom see him as a danger to America. All of which, given the ideological standpoint of the authors, might be music to DeSantis’ ears. “We are excited to see our efforts are paying off. Support for Ron DeSantis continues to grow. While we expect the attacks to increase, we are delighted his support base is increasing too,” explained Ready for Ron legal counsel and spokeswoman Lilian Rodríguez-Baz. “We are hoping to build one of the biggest grassroots movements ever, and with support growing like this, it will happen even more quickly than we anticipated.” Ready for Ron continues its TV and online advertising efforts to engage Americans to sign the petition at ReadyForRon.com to Draft Ron DeSantis to run in 2024. While ‘Ready for Ron’ is completely unaffiliated with the DeSantis campaign per federal regulations, it has taken the novel step of submitting a formal Advisory Opinion Request to the FEC seeking to share its growing supporter list with Governor DeSantis if the Draft succeeds and he announces his candidacy. Impact Social is a specialist social media, online monitoring, and analysis company. It uses big data software to track over 60 million online sites including Twitter, Facebook, all blogs, forums, and news websites. Whatever is said publicly, in the media or online it can follow live, 24/7 in 44 different languages. This is where reliance on algorithms ends. Once the data has been received its in-house experts read and analyze the content - often amounting to 1,000’s of individual posts. Impact Social’s unique methodology ensures unrivalled accuracy to show what has been said and its impact. Impact Social is the only company in the world providing this level of analysis. ### For more information or to schedule an interview with ‘Ready for Ron’ legal counsel, Lilian Rodríguez-Baz, or an Impact Social spokesperson, please contact Dan Rene at 202-329-8357 or dan@readyforron.com Contact Details Dan Rene +1 202-329-8357 dan@readyforron.com Company Website https://www.readyforron.com/

July 11, 2022 10:17 AM Eastern Daylight Time

Dr. Nirmal Joshi Named Chair of Patient Safety Authority Board

Patient Safety Authority

Governor Tom Wolf has appointed Nirmal Joshi, MD, FACP, as chair of the Patient Safety Authority (PSA) board of directors. Dr. Joshi succeeds Dr. Denise Johnson, Acting Secretary of Health and Physician General for Pennsylvania, who served as PSA’s board chair for the past year. An internal medicine physician, Dr. Joshi brings extensive experience in clinical quality, patient safety, research, and executive leadership to the role. He currently serves as the chief medical officer of Population Health for Mount Nittany Health System in State College. He is also president of the Joshi Health Foundation in Mechanicsburg—a nonprofit organization he founded to provide free healthcare to those who are unable to afford it. In 2016, Becker’s Hospital Review recognized him as one of “100 hospital and system CMOs to know.” He was also named one of “150 Living Legacy Contributors” to the Capital City by the Harrisburg SusqueCentennial Commission. Dr. Joshi has served on the Board of Asian Indian Americans of Central PA and the State Board of Medicine and has helped start new health systems in India where he began his medical education. Dr. Joshi received his Bachelor of Medicine-Bachelor of Surgery from King George Medical College and fellowship training in infectious diseases from the Milton S. Hershey Medical Center. “My special interests in clinical quality, patient safety, and improving physician-patient communication align with PSA’s work to bring awareness of issues and advance best practices in patient safety,” said Dr. Joshi. “I am honored and pleased to lead an organization that is driving these ideas and offering solutions in Pennsylvania and around the globe.” “Dr. Joshi’s passion for clinical quality and patient safety, his extensive experience in executive leadership, and his humanitarian approach are a welcome addition to the PSA,” said Regina Hoffman, executive director. “We are very much looking forward to having him at the helm.” Today, Pennsylvania leads the country in patient safety advocacy as the only U.S. state that requires healthcare facilities to report harmful events, as well as those that do not result in patient harm (i.e., near misses) but may be a harbinger of a potentially serious problem. The PSA analyzes those events, facilitates statewide performance improvement projects, and shares the information globally. The PSA is an independent state agency that collects and analyzes patient safety data to improve safety outcomes and help prevent patient harm. http://patientsafety.pa.gov/ About PSA Established under the Medical Care Availability and Reduction of Error (MCARE) Act of 2002, the PSA, an independent state agency, collects and analyzes patient safety data to improve safety outcomes and help prevent patient harm. http://patientsafety.pa.gov/ Contact Details Bev Volpe +1 609-230-4696 bev@madisongall.com Company Website http://patientsafety.pa.gov/

July 08, 2022 10:00 AM Eastern Daylight Time

Image

Healthcare

Elsevier partners with the Society for Mucosal Immunology to publish Mucosal Immunology

Asia’s only diagnostic-first sexual health wellness startup Kindly secures funding round

Unocoin Collaborates With CleverTap to Offer Its Users Omnichannel Customer Experiences

#scheinchat: How to Optimize Billing in the Dental Practice

Elsevier Launches Global Collaboration to Understand the Impact of the Pandemic on Confidence in Scientific Research

Nearly Half a Million Young People Are Quitting E-cigarettes Through Text: First-of-its-kind program from truth® is helping young people quit vaping nicotine

Lauren Lawson-Zilai Joins Shatterproof® as Senior Director, Media and Public Relations

‘Ready for Ron’ Releases Research Illustrating Growing Positive Sentiment for DeSantis

Dr. Nirmal Joshi Named Chair of Patient Safety Authority Board